Board approves name change, adds pharma and chemicals to business objects

Sattva Sukun Lifecare board approved a proposed name change to Tavexia, Trumaxa, Trustarex or Tradamex Lifecare Limited, subject to CRC and shareholder approval. The Object Clause of the MOA was also expanded to add businesses in chemicals, specialty chemicals, pharmaceuticals, APIs, nutraceuticals, biotech, CRO/CDMO/CRAMS services, R&D and intellectual property. Two directors, Sachin Manseta and Chirag Dedhia, were regularized for 5-year terms from July 22, 2026. An EGM will be held to seek shareholder approval for these changes.